<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00727493</url>
  </required_header>
  <id_info>
    <org_study_id>OPOZAHN</org_study_id>
    <nct_id>NCT00727493</nct_id>
  </id_info>
  <brief_title>Osteoporosis and Dental Implant</brief_title>
  <acronym>OPOZAHN</acronym>
  <official_title>Evaluation of the Influence of Alendronate on Wound Healing After Dental Implants in Patients With Osteoporosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the influence of alendronate therapy on the wound
      healing after dental implants in patients with osteoporosis.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2004</start_date>
  <completion_date type="Anticipated">April 2010</completion_date>
  <primary_completion_date type="Anticipated">January 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dental CT</measure>
    <time_frame>baseline, and 3,6,12 months after baseline</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Osteoporosis</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>alendronate once weekly 70mg, calcium 1000mg and Vitamin D 800 IU daily, dental implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo once weekly, calcium 1000mg and Vitamin D 800 IU daily; dental implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>dental implant, calcium 1000mg and Vitamin D 800 IU daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>alendronate once weekly 70mg</intervention_name>
    <description>alendronate once weekly 70mg, calcium 1000mg and Vitamin D 800 IU daily for 12 months, dental implant</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>placebo once weekly; calcium 1000mg and Vitamin D 800 IU daily, dental implant</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Postmenopausal women &gt; 2 years after menopause

          -  Age between 60 and 75 years

          -  Possibility to insert a dental implant

          -  Osteoporosis as defined by WHO criteria (intervention group), or women without
             osteoporosis / osteopenia (non-intervention group)

        Exclusion Criteria:

          -  Pathological findings in the jaw bone

          -  Chronic inflammatory rheumatoid disease

          -  Bisphosphonate treatments during the last 12 months

          -  Inflammatory or metabolic bone disease, excluding osteoporosis

          -  Systemic corticosteroid treatments of more than one month within previous 12 months

          -  Severe diseases with life expectancy less than one year or expectation of rapid
             worsening within one year
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dieter Felsenberg, Prof. D.r</last_name>
    <role>Study Chair</role>
    <affiliation>Leader of the center for muscle and bone research, Charité</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dieter Felsenberg, Prof. Dr.</last_name>
    <phone>+490384453046</phone>
    <email>dieter.felsenberg@charite.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hendrikje Boerst, Dipl. Wiss org.</last_name>
    <phone>+490384454745</phone>
    <email>hendrikje.boerst@charite.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre for Muscle and Bone Research, Charité - Campus Benjamin Franklin</name>
      <address>
        <city>Berlin</city>
        <zip>12200</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dieter Felsenberg, Prof. Dr.</last_name>
      <phone>+493084453046</phone>
    </contact>
    <contact_backup>
      <last_name>Hendrikje Boerst, Dipl. Wiss. org.</last_name>
      <phone>+493084454745</phone>
      <email>hendrikje.boerst@charite.de</email>
    </contact_backup>
    <investigator>
      <last_name>Dieter Felsenberg, Prof. Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anton ° Friedman, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 31, 2008</study_first_submitted>
  <study_first_submitted_qc>August 1, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 4, 2008</study_first_posted>
  <last_update_submitted>August 1, 2008</last_update_submitted>
  <last_update_submitted_qc>August 1, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 4, 2008</last_update_posted>
  <responsible_party>
    <name_title>Prof. Dr. med. Dieter Felsenberg</name_title>
    <organization>Center for Muscle and Bone Research</organization>
  </responsible_party>
  <keyword>osteoporosis,</keyword>
  <keyword>bisphosphonate</keyword>
  <keyword>therapy</keyword>
  <keyword>dental implant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Alendronate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

